Physician profile
Jaya Thomas
NPI 1477501294
$4,634.40
in general payments reported to CMS, 2019-2025
22 companies · $358 in 2025
The $358 reported for 2025 was more than what 88% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $824 · 2020: $1,571 · 2021: $284 · 2022: $585 · 2023: $474 · 2024: $538 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,411.46 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $542.88 | 2019-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $497.09 | 2019-2025 | Xarelto, Uptravi |
| Lantheus Medical Imaging, INC. | $250.73 | 2019-2024 | |
| Lexicon Pharmaceuticals, INC. | $248.74 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $244.32 | 2020-2025 | Verquvo, Vaxneuvance, Gardasil 9 |
| Boston Scientific Corporation | $209.57 | 2019-2024 | Watchman Access System |
| Bayer Healthcare Pharmaceuticals INC. | $204.30 | 2022-2023 | |
| Alnylam Pharmaceuticals INC. | $196.74 | 2022-2023 | Onpattro |
| Cranial Technologies, INC | $178.60 | 2019-2025 | Doc Band |
| Amgen INC. | $129.98 | 2019 | |
| Edwards Lifesciences Corporation | $128.90 | 2024 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $95.51 | 2019-2025 | Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $82.90 | 2019-2022 | |
| Inspire Medical Systems, INC. | $57.61 | 2023-2025 | Inspire |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.36 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $27.73 | 2025 | Evkeeza, Praluent |
| Ionis Pharmaceuticals, INC. | $26.03 | 2025 | Tryngolza |
| Amarin Pharma, INC. | $18.15 | 2019 | |
| Phadia US INC. | $15.00 | 2019 | |
| Tactile Systems Technology INC | $13.01 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaya Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.